EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Studies on the toluene 2 4 diisocyanate induced shape change of human erythrocytes


Journal of Tokyo Women's Medical College 54(7): 581-594
Studies on the toluene 2 4 diisocyanate induced shape change of human erythrocytes
The biconcave discoid shape of normal human erythrocytes can be altered into cup-shaped cells by bifunctional reagent toluene 2,4-diisocyanate (TDI). The extent of TDI-induced shape change of the erythrocytes seems to be correlative to the concentration of TDI. The resultant modified red cells were in progressive decrease in the filtrability as measured by microporous membrane and also an increase in resistance to hemolysis against water. Isolated membranes obtained from TDI-treated cells showed cross-linking of membrane proteins and phospholipids, mainly of spectrin, phosphatidylethanolamine and phosphatidylserine, during shape change in different degree according to the concentration of TDI. Isolated erythrocyte ghosts underwent TDI-dependent shape that was similar to intact cells. After treating control ghosts with trypsin, some bands, including spectrin, band 2.1 and 4.1 disappeared concomitantly on polyacrylamide gel electrophoresis. Apparently, membrane proteins, cytoskeletal network underlying erythrocyte membranes, are necessary for maintaining and changing the shape of red cells.


Accession: 006522534



Related references

Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: Useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Clinical & Experimental Allergy 32(4): 551-555, April, 2002

Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Clinical and Experimental Allergy 32(4): 551-555, 2002

Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clinical & Experimental Allergy 33(1): 113-118, January, 2003

Serum specific IgG response to toluene diisocyanate-tissue transglutaminase conjugate in toluene diisocyanate-induced occupational asthmatics. Annals of Allergy, Asthma & Immunology 113(1): 48-54, 2014

Toluene-diisocyanate-induced asthma. 2. Histamine liberation test using leukocytes from toluene-diisocyanate sensitized guinea pigs. Arerugi 32(3): 131-137, 1983

Toluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma. Clinical and Experimental Immunology 160(3): 489-497, 2010

Experimental studies on toluene-diisocyanate (TDI) specific IgG antibodies. (I). Detection in the serum from toluene-diisocyanate skin-sensitized mice. Arerugi 34(11): 1040-1049, 1985

Experimental studies on toluene diisocyanate specific immunoglobulin g antibodies 1. detection in the serum from toluene diisocyanate skin sensitized mouse. Japanese Journal of Allergology 34(11): 1040-1049, 1985

Quantitative determination of hexamethylene diisocyanate (HDI), 2,4-toluene diisocyanate (2,4-TDI) and 2,6-toluene diisocyanate (2,6-TDI) monomers at ppt levels in air by alkaline adduct coordination ionspray tandem mass spectrometry. Journal of Environmental Monitoring 7(2): 145-150, 2005

Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. American Journal of Respiratory and Critical Care Medicine 162(2 Pt 1): 516-522, 2000